Literature DB >> 2201022

Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice.

C Ledent1, M Parmentier, G Vassart.   

Abstract

Fusion genes containing 1600 or 2000 base pairs of the bovine thyroglobulin gene 5' flanking region and the chloramphenicol acetyltransferase (CAT) coding sequence were constructed and used to generate transgenic mice. Altogether, 24 independent transgenic lines were obtained, and the expression of the transgene was assayed by measuring the CAT activity in different tissues. Depending on the transgenic lines, the fusion gene was either silent in all tissues or specifically expressed in the thyroid. The level of expression was found to be highly variable from one line to another and to be regulated by thyrotropin in a manner similar to the natural thyroglobulin gene. The methylation status of the integrated DNA was tested by digestion of DNA extracted from thyroid and other tissues with the isochizomers Msp I and Hpa II. It was found that one of the Hpa II sites was demethylated specifically in the thyroid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201022      PMCID: PMC54495          DOI: 10.1073/pnas.87.16.6176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting.

Authors:  J L Swain; T A Stewart; P Leder
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

2.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

3.  A dominant control region from the human beta-globin locus conferring integration site-independent gene expression.

Authors:  D Talbot; P Collis; M Antoniou; M Vidal; F Grosveld; D R Greaves
Journal:  Nature       Date:  1989-03-23       Impact factor: 49.962

4.  The formation and function of DNase I hypersensitive sites in the process of gene activation.

Authors:  S C Elgin
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

5.  Thyroid-specific and cAMP-dependent hypersensitive regions in thyroglobulin gene chromatin.

Authors:  C Hansen; C Gerard; G Vassart; P Stordeur; D Christophe
Journal:  Eur J Biochem       Date:  1988-12-15

6.  Transgenic mice overexpressing the mouse homoeobox-containing gene Hox-1.4 exhibit abnormal gut development.

Authors:  D J Wolgemuth; R R Behringer; M P Mostoller; R L Brinster; R D Palmiter
Journal:  Nature       Date:  1989-02-02       Impact factor: 49.962

7.  Induction of nuclear protein factors specific for hormone-responsive region during activation of thyroglobulin gene by thyrotropin in rat thyroid FRTL-5 cells.

Authors:  N T Lee; S N Nayfeh; C B Chae
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

8.  A cell type specific factor recognizes the rat thyroglobulin promoter.

Authors:  A M Musti; V M Ursini; E V Avvedimento; V Zimarino; R Di Lauro
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

9.  N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.

Authors:  H Rosenbaum; E Webb; J M Adams; S Cory; A W Harris
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

10.  Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.

Authors:  N Sarvetnick; D Liggitt; S L Pitts; S E Hansen; T A Stewart
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

View more
  12 in total

1.  Dominant protein interactions that influence the pathogenesis of conformational diseases.

Authors:  Jordan Wright; Xiaofan Wang; Leena Haataja; Aaron P Kellogg; Jaemin Lee; Ming Liu; Peter Arvan
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

2.  Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.

Authors:  Nicholas C Souders; Duane A Sewell; Zhen-Kun Pan; S Farzana Hussain; Alexander Rodriguez; Anu Wallecha; Yvonne Paterson
Journal:  Cancer Immun       Date:  2007-02-06

Review 3.  Molecular events in the differentiation of the thyroid gland.

Authors:  R Di Lauro; G Damante; M De Felice; M I Arnone; K Sato; R Lonigro; M Zannini
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

Review 4.  Positive control of proliferation by the cyclic AMP cascade: an oncogenic mechanism of hyper-functional adenoma.

Authors:  C Ledent; J Parma; I Pirson; M Taton; P Roger; C Maenhaut; J Van Saude; V Pohl; F Lamy; M Parmentier
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

5.  Unmethylated thyroglobulin promoter may be repressed by methylation of flanking DNA sequences.

Authors:  B Pichon; C Christophe-Hobertus; G Vassart; D Christophe
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

6.  Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid.

Authors:  P Caturegli; M Hejazi; K Suzuki; O Dohan; N Carrasco; L D Kohn; N R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice.

Authors:  Marcio O Lasaro; Marina Sazanovich; Wynetta Giles-Davis; Paulus Mrass; Ralph M Bunte; Duane A Sewell; S Farzana Hussain; Yang-Xin Fu; Wolfgang Weninger; Yvonne Paterson; Hildegund Cj Ertl
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

8.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

9.  Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice.

Authors:  F M Michiels; B Caillou; M Talbot; F Dessarps-Freichey; M T Maunoury; M Schlumberger; L Mercken; R Monier; J Feunteun
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism.

Authors:  C Ledent; J E Dumont; G Vassart; M Parmentier
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.